about
The potential impact of male circumcision on HIV in Sub-Saharan AfricaThe Strong Protective Effect of Circumcision against Cancer of the PenisVoluntary medical male circumcision: an introduction to the cost, impact, and challenges of accelerated scaling upMale circumcision for HIV prevention in high HIV prevalence settings: what can mathematical modelling contribute to informed decision making?Voluntary medical male circumcision: an HIV prevention priority for PEPFARReview: a critical evaluation of arguments opposing male circumcision for HIV prevention in developed countriesHealthcare Programmes for Truck Drivers in Sub-Saharan Africa: A Systematic Review and Meta-Analysis.Male circumcision and risk of HIV infection in women: a systematic review and meta-analysisMale circumcision for HIV prevention: current research and programmatic issuesThe cost and impact of scaling up pre-exposure prophylaxis for HIV prevention: a systematic review of cost-effectiveness modelling studiesVoluntary medical male circumcision: a framework analysis of policy and program implementation in eastern and southern AfricaAsking the right questions: developing evidence-based strategies for treating HIV in women and childrenImproving Maternal Care through a State-Wide Health Insurance Program: A Cost and Cost-Effectiveness Study in Rural Nigeria.VMMC Devices-Introducing a New Innovation to a Public Health InterventionVoluntary Medical Male Circumcision for HIV Prevention: New Mathematical Models for Strategic Demand Creation Prioritizing Subpopulations by Age and Geography.Human papillomavirus type 16 viral load is higher in human immunodeficiency virus-seropositive women with high-grade squamous intraepithelial lesions than in those with normal cytology smearsUse of PGMY primers in L1 consensus PCR improves detection of human papillomavirus DNA in genital samples.Nonisotopic detection of human papillomavirus DNA in clinical specimens using a consensus PCR and a generic probe mix in an enzyme-linked immunosorbent assay formatPlanning for pre-exposure prophylaxis to prevent HIV transmission: challenges and opportunities.Voluntary medical male circumcision: modeling the impact and cost of expanding male circumcision for HIV prevention in eastern and southern AfricaVoluntary medical male circumcision: a qualitative study exploring the challenges of costing demand creation in eastern and southern AfricaEnhanced detection and typing of human papillomavirus (HPV) DNA in anogenital samples with PGMY primers and the Linear array HPV genotyping test.Transmission of HIV-1 infection in sub-Saharan Africa and effect of elimination of unsafe injections.Gender-sensitive reporting in medical research.Translating PrEP effectiveness into public health impact: key considerations for decision-makers on cost-effectiveness, price, regulatory issues, distributive justice and advocacy for access.Modeling the impact of RV144-like vaccines on HIV transmissionImpact and Cost of Scaling Up Voluntary Medical Male Circumcision for HIV Prevention in the Context of the New 90-90-90 HIV Treatment TargetsConfirmatory real-time PCR assay for human papillomavirus (HPV) type 52 infection in anogenital specimens screened for HPV infection with the linear array HPV genotyping testAno-genital human papillomavirus type 97 infection is detected in Canadian men but not women at risk or infected with the human immunodeficiency virusAntiretroviral therapy in prevention of HIV and TB: update on current research effortsTowards universal access to HIV prevention, treatment, care, and support: the role of tuberculosis/HIV collaboration.Estimation of country-specific and global prevalence of male circumcision.Impact evaluation of a community-based intervention for prevention of cardiovascular diseases in the slums of Nairobi: the SCALE-UP study.Global challenges keynote address in memoriam to colleagues lost in the Malaysia airlines 17 crashOverview of the current state of the epidemic.Ethical considerations in determining standard of prevention packages for HIV prevention trials: examining PrEP.Assessing Progress, Impact, and Next Steps in Rolling Out Voluntary Medical Male Circumcision for HIV Prevention in 14 Priority Countries in Eastern and Southern Africa through 2014.Gender, sex, and HIV: how well are we addressing the imbalance?The promise of pre-exposure prophylaxis with antiretroviral drugs to prevent HIV transmission: a review.Male circumcision as an HIV prevention strategy in sub-Saharan Africa: sociolegal barriers.
P50
Q21144704-6EB77C12-E7B2-4336-89E9-F74B2C512097Q21296754-1F56D4F8-7182-40C2-92EC-FF539D21B4B8Q21563036-F96F4024-364F-4C88-B49F-D66708F0EB01Q21563397-B5B439D7-D079-43A3-BED6-399E6BB5F943Q24621413-5DE4417A-E0DD-4763-8866-F6B053BC7EBAQ24621538-804BD5F8-AAA5-4603-AD82-D6AF7B7D3AD7Q27340238-CD7E6569-F0D9-4DDF-9CF9-E6196C218D65Q28262269-5F7C28D6-E17D-42F4-AA89-69139B76F4C5Q28297402-B047294B-C658-44DE-9437-21760BAD53BEQ28487926-C6BC9C47-F145-4198-B5C8-C565FF84EFDCQ28742179-D86F159A-A59A-43DB-A3C7-CCF39F80F02BQ28743488-EAE7A3C9-AFF4-461A-B759-7DE3B55679EAQ30062123-12E5A7C2-2C35-4DA4-9C95-73CCD1206F87Q30382611-D4C4E906-B180-42FA-8FC8-B5201032700FQ30394526-77AEA265-78E9-49DC-9B51-9D516FEE7626Q33715294-D5200E97-59F7-4848-89F9-0BE0E71A45DAQ33950256-9239ADEF-6E58-40D7-BC61-09BCC83A1BA8Q33973621-48A1576B-3DA0-4CE8-AC5C-C8CEA8A97551Q34036470-3534330E-8EFF-49D9-8D74-F0532E51708EQ34090912-D989B634-D0C2-4423-8165-6CCA7867B851Q34090990-7A7C4237-5D5F-44E8-A7EC-A7060A8159F5Q34719623-ECD962E7-DAA2-42F1-A008-D2CA8115810EQ35666921-DBD57824-E9A1-4ADF-B642-256A9524F78EQ35856500-988B6D4E-7384-4248-8776-C6EE95AE7189Q35875746-92B7A6CC-FCF5-4C09-B67D-071FF6302701Q36086562-6E6112B2-EE31-4DC2-9375-FAF018F0DB09Q36175057-DE347ABD-162A-45C8-B6E8-957D68CC1AF8Q36314457-A45E9BC2-F958-4D5D-BE97-E917C6310A7EQ36402443-A92D2834-F48D-4F01-8C1D-D34ACB7F939DQ36493044-09363079-504A-4DEC-82E8-019E64ADF087Q36548072-83754D37-9930-40C2-A123-ADE4CC72C719Q36634171-616D24A7-92FA-459C-938F-D5F714C41BDCQ36731560-36B524A9-BC5E-4E43-BEF1-A704959BCA3DQ36789620-D52FD2B5-BAE0-46FD-A19A-2329BFBB19FEQ36812534-534DC473-D57B-4CA2-A4DA-8412EE788B65Q37028167-20A2E7DE-F231-4333-8D29-0B99ECD5D7FCQ37114210-32477E0D-80F0-4291-A2B2-B59067257A70Q37447829-1FEDD0F4-9C6F-4897-92A6-D60487FA9D47Q38064243-F7DE8A70-F210-46DC-85C3-F9BA3A8489DFQ39029649-77C623E8-D7E7-41FF-B8E1-884738C4F9B6
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
ricercatrice
@it
հետազոտող
@hy
name
Catherine Hankins
@ast
Catherine Hankins
@en
Catherine Hankins
@es
Catherine Hankins
@fr
Catherine Hankins
@nl
Catherine Hankins
@sl
type
label
Catherine Hankins
@ast
Catherine Hankins
@en
Catherine Hankins
@es
Catherine Hankins
@fr
Catherine Hankins
@nl
Catherine Hankins
@sl
prefLabel
Catherine Hankins
@ast
Catherine Hankins
@en
Catherine Hankins
@es
Catherine Hankins
@fr
Catherine Hankins
@nl
Catherine Hankins
@sl
P106
P1153
35832461700
P21
P214
5300154075997011860001
P31
P496
0000-0002-1642-8592
P735
P7859
viaf-5300154075997011860001